Concord Medical Services Holdings Ltd (CCM) FinancialsCCMConcord Medical Services Holdings Ltd

Evaluating the bottom line, Concord Medical Services Holdings Ltd maintains a gross margin of 11.58%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -1.35%, while the net margin is -25.27%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively CCM converts its operational activities into shareholder value.

In the context of the broader market, CCM competes directly with industry leaders such as DYAI and RADX. With a market capitalization of $16.10M, it holds a significant position in the sector. When comparing efficiency, CCM's gross margin of 11.58% stands against DYAI's -2.40% and RADX's -90.30%. Such benchmarking helps identify whether Concord Medical Services Holdings Ltd is trading at a premium or discount relative to its financial performance.

The company reported a gross margin of 11.58% in Q3 2025, a notable improvement from previous quarters, indicating a positive trend in profitability. However, it also reported a net loss of 32.8 million CNY, which raises concerns about its financial stability.